Search results for "FDA approval"

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug application for its dual-antibody...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an Orphan Drug for the treatment...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...
Treating Depression with Brain Stimulation Without Medication

Treating Depression with Brain Stimulation Without Medication

The Busan On Hospital Mental Health Promotion Center (Director Kim Sang-yeop) has introduced Transcranial Magnetic...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?

The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?

A, who has entered her mid-40s this year, has been feeling increasingly depressed when standing in front of the mirror...
BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

The hypertrophic cardiomyopathy treatment drug 'Camzyos (generic name mavacamten)' is expected to be prescribed for...
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in...
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?

Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.